Cosmo Pharmaceuticals N.V.

SWX:COPN 주식 보고서

시가총액: CHF 1.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cosmo Pharmaceuticals 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Giovanni Di Napoli

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간3.5yrs
이사회 평균 재임 기간less than a year

최근 관리 업데이트

Recent updates

Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

May 02
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 28
Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Mar 26
Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Dec 01
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 29
Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Nov 24
We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

Mar 31
Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

May 20
Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

Apr 03
Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Mar 07
When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

What Kind Of Investors Own Most Of Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Feb 01
What Kind Of Investors Own Most Of Cosmo Pharmaceuticals N.V. (VTX:COPN)?

CEO

Giovanni Di Napoli (50 yo)

less than a year

테뉴어

Mr. Giovanni Di Napoli is Chief Executive Officer and Director of Cosmo Pharmaceuticals N.V. from May 24, 2024. He was President of Gastrointestinal at Medtronic plc. He is an accomplished leader with an e...


리더십 팀

이름위치테뉴어보상소유권
Alessandro Della Cha
Executive Chairman18.5yrs€1.16m데이터 없음
Niall Donnelly
Executive Director & CFO8.1yrs데이터 없음데이터 없음
Giovanni Di Napoli
Chief Executive Officer & Directorless than a year데이터 없음데이터 없음
Mauro Ajani
Founder & Non-Executive Director18.5yrs€400.00k데이터 없음
Marco Lecchi
Chief Operating Officer3.5yrs데이터 없음데이터 없음
Davide Malavasi
Qualified Person & Technical Director12.8yrs데이터 없음데이터 없음
Luigi Longo
Chief Scientific Officer2.3yrs데이터 없음데이터 없음
Hazel Winchester
Head of Investor Relations2.5yrs데이터 없음데이터 없음
Biagio Vigano
Chief People Officer3.5yrs데이터 없음데이터 없음
Roberto Villa
Chief Manufacturing Officer27.5yrs데이터 없음데이터 없음
Ngo Nhan
President of Cosmo Intelligent Medical Devicesno data데이터 없음데이터 없음
Andrea Cherubini
SVP of Science4.5yrs데이터 없음데이터 없음

3.5yrs

평균 재임 기간

51.5yo

평균 연령

경험이 풍부한 관리: COPN 의 관리팀은 경험 ( 3.4 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Alessandro Della Cha
Executive Chairman18.5yrs€1.16m데이터 없음
Niall Donnelly
Executive Director & CFOless than a year데이터 없음데이터 없음
Giovanni Di Napoli
Chief Executive Officer & Directorless than a year데이터 없음데이터 없음
Mauro Ajani
Founder & Non-Executive Director18.5yrs€400.00k데이터 없음
William Sandborn
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Geert D'Haens
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Silvio Danese
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Maria Roncarolo
Non-Executive Director12.3yrs€128.79k데이터 없음
Ralf Kiesslich
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Robert Steffen
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Silvana Perretta
Non-Executive Directorless than a year데이터 없음데이터 없음
John O'Dea
Non-Executive Directorless than a year데이터 없음데이터 없음

0.2yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: COPN 의 이사회경험(평균 재직 기간 0.1 년)으로 간주되지 않으므로 새 이사회가 필요합니다.